TREA

90151421 - EFTEKI

Follow

Information

  • Trademark
  • 90151421
  • Serial Number
    90151421
  • Registration Number
    6841826
  • Filing Date
    September 01, 2020
    4 years ago
  • Registration Date
    September 13, 2022
    2 years ago
  • Transaction Date
    September 13, 2022
    2 years ago
  • Status Date
    September 13, 2022
    2 years ago
  • Published for Opposition Date
    June 28, 2022
    2 years ago
  • Location Date
    September 13, 2022
    2 years ago
Information
Mark Drawing Code
4000
Mark Identification
EFTEKI
Case File Statements
  • GS0051: Medicines for dental purposes; Chemical preparations for medical purposes for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antibiotics; Injectable medicines for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Medicine in tablet form for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs sold in bulk for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antiseptics; Collyrium; Hemorrhoidal suppositories, laxative suppositories, or vaginal suppositories for the prevention and treatment of infections; Medical paster, namely, medical plasters; Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Medicated sweets; Candy for medical purposes; Dietetic foods adapted for medical purposes; Dietetic beverages adapted for medical purposes; Dietetic preparations adapted for medical purposes; Medicinal oils; Mineral food supplements; Nutritional supplements; Medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Bacterial poisons; Pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Radioactive substances for medical purposes; Gases for medical purposes, namely, nitric oxide for medical purposes; Chemical conductors for electrocardiograph electrodes; Semen for artificial insemination; Disinfectants; Solutions for contact lenses; Media for bacteriological cultures; Depuratives for the body; Diagnostic preparations for veterinary purposes; Pesticides; Sanitary napkins; Cotton for medical purposes; Dental abrasives; Diapers for pets
Case File Event Statements
  • 9/13/2022 - 2 years ago
    27 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 9/13/2022 - 2 years ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/28/2022 - 2 years ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/28/2022 - 2 years ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/8/2022 - 2 years ago
    23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/18/2022 - 2 years ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/17/2022 - 2 years ago
    21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/17/2022 - 2 years ago
    20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/17/2022 - 2 years ago
    19 - ASSIGNED TO LIE Type: ALIE
  • 5/12/2022 - 2 years ago
    18 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 12/1/2021 - 3 years ago
    17 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 12/1/2021 - 3 years ago
    16 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 12/1/2021 - 3 years ago
    15 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 11/24/2021 - 3 years ago
    14 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 5/24/2021 - 3 years ago
    13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 5/24/2021 - 3 years ago
    12 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 5/24/2021 - 3 years ago
    11 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 5/12/2021 - 3 years ago
    10 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/31/2021 - 3 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/30/2021 - 3 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/30/2021 - 3 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/8/2021 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/8/2021 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/8/2021 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/5/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/6/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 9/4/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP